Patient: Page 17
-
Patient Access: Keeping the Channel Open During a Crisis
A managed access program enables pharmaceutical and biotechnology companies to make certain investigational or unapproved treatments available to eligible patients through their prescribing physicians. But what happens when the supply chain is disrupted by a pandemic, such as COVID-19? The worldw...
By Carolyn Gretton • May 1, 2020 -
Commanders & Chiefs
The role of chief technology officer has become more encompassing as companies adopt new software and technology-based solutions to solve some of their biggest challenges and create opportunities for new rewards. Zaher El-Assi Decentralizing & Accelerating Trials Next-generation innovations t...
By PharmaVoice Team • May 1, 2020 -
Explore the Trendline➔
Stock via Getty ImagesTrendlineCommercialization, marketing and social media
As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.
By PharmaVoice staff -
Upfront
BMS Undergoes Brand Transformation Bristol Myers Squibb has revealed a new brand to reflect its evolution in light of its acquisition of Celgene for $74 billion late last year. The changes reflect an updated website, logo, and a change in punctuation — removing the hyphen between Bristol and Myer...
By PharmaVoice Team • April 1, 2020 -
HealthTech
Boehringer-Ingelheim Launches Patient-Centric MyStudyWindow Powered by Carebox Trend Watch: HealthTech Innovations Continue to Transform Patient Care Boehringer Ingelheim and Carebox Healthcare Solutions have launched MyStudyWindow, a digital platform empowering patients, families, caregivers, an...
By PharmaVoice Team • April 1, 2020 -
HBA's Rising Stars and Luminaries
The HBA’s 2020 Rising Stars and Luminaries provide their insights on the trends they are tracking that they believe will impact the industry in the future. In 2020, the Healthcare Businesswomen’s Association is honoring more than 140 extraordinary women representing all facets of the life-science...
By PharmaVoice Team • April 1, 2020 -
Letter from the Editor
The patient experience We are excited to publish the third annual Patient Voice issue. This special publication is dedicated to raising the voice of patients and sharing their insights on topics ranging from drug discovery and development through commercialization. We also have tapped nearly 100 ...
By Taren Grom • March 1, 2020 -
Upfront
Teva and Direct Relief Partner to Bring Cancer Medicines to Africa Global HOPE (Hematology-Oncology Pediatric Excellence), a program of Texas Children’s Hospital, Teva Pharmaceutical Industries, and Direct Relief are partnering to provide access to medications in sub-Saharan Africa, where a major...
By PharmaVoice Team • March 1, 2020 -
The Power of Patients
Patient engagement is permeating all spheres of the healthcare ecosystem. On the cover… This month’s cover image is a self-portrait painted by Casey Ford, age 19, who has a rare connective tissue disorder, which is characterized by under-developed, absent, or misplaced/misaligned kneecaps in newb...
By Taren Grom • March 1, 2020 -
Patient Gallery
Last year, we were honored to feature the art work of Max Schill, now 11, who remains an active patient advocate, and who helped pass the 21st Century Cure Act. We are excited to continue this tradition with this year’s original artwork by 19-year-old Casey Ford. To expand the patient gallery we ...
By Robin Robinson • March 1, 2020 -
Driving Patient Engagement
A cultural shift throughout pharma is putting patients squarely in the middle of strategic decision-making. Pharmaceutical companies should take a cue from patient advocacy groups to drive patient engagement, and even partner with those advocacy organizations to create better patient experiences ...
By Taren Grom • March 1, 2020 -
Patient Stories Can Bridge the Gap Between Pharma and Patients
Patients are sharing their stories in an effort to educate other stakeholders, and the pharma industry is using that knowledge sharing to improve on messaging and patient interaction. Patient stories are being used to illustrate organizations’ brand, services, and successes. Hospitals are using t...
By PharmaVoice Team • March 1, 2020 -
Patient-Enhanced Drug Discovery and Development
Patients are uniquely positioned to inform the understanding of the therapeutic context for drug development and evaluation. In other industries, it would seem odd not to get input from the end user of a product throughout the development stages. But it seems that pharmaceutical companies — some ...
By Taren Grom • March 1, 2020 -
Bringing the Patient Voice into Clinical Trials
In an effort to put patients at the center, pharmaceutical companies are starting to gather input from patients earlier in the clinical trial process. Amid growing recognition that patients need to be part of the decision-making process in order to increase the effectiveness of the study, the pha...
By PharmaVoice Team • March 1, 2020 -
Building Advocacy Partnerships
The relationship between pharma companies and advocacy groups is important for all stakeholders but more needs to be done to create truly interactive, transparent relationships. The most effective approach for pharma companies to truly be patient-minded is a combination of engaging with patients ...
By PharmaVoice Team • March 1, 2020 -
Patient Relationships: Physicians and Payers
Patients are taking an active role in developing relationships with all stakeholders within their healthcare environment. Over the past several years, the relationship between pharma companies and patients has garnered much of the industry’s attention. But as patients become more empowered, engag...
By Robin Robinson • March 1, 2020 -
A Different Kind of Real-World Evidence: The Key Role That Patient-Provider Dialogue Research Can Play
All roads in healthcare lead to and from the medical visit. Well, maybe not all roads, but nearly all. The medical visit is central to the overarching healthcare structure and it is driven by the dialogue between patient and provider. The healthcare data and research landscape has been changing s...
By Katy Hewett • March 1, 2020 -
Patient Heroes
The definition of a hero is a person who is admired for courage, outstanding achievements, or noble qualities. There is a massive demand for patient-engagement solutions, with predictions that the market for such solutions will reach $30.36 billion by 2026. Patient needs are not only supported by...
By PharmaVoice Team • March 1, 2020 -
Making the Patient an Extension of the Team
The concept of patient-centricity is well embedded throughout EVERSANA and is intrinsically tied to helping the agency’s clients achieve their goals. Kristin LaBounty Phillips believes that the entire agency — with a unified commitment to quality in addressing patients’ needs — embodies the conce...
By Kristin LaBounty Phillips • March 1, 2020 -
Breaking Down Barriers to Bring Patients Equal Access to Top-Quality Care
Patients Always The term “patients first" is not enough, rather it’s “patients always" because patients are our North Star through every stage of development — from discovery to clinical trials to approved treatment. Eve Dryer Executive Director, Patient Advocacy Retrophin All patients should hav...
By Eve Dryer • March 1, 2020 -
Clinical Educators Provide Support Along the Whole Patient Journey
Team Power The teams of clinical educators at VMS BioMarketing are driven to help patients on a one-to-one basis to manage chronic illnesses — in the field or on the phone each day. Taking A Step-Wise Approach to clinical education There is one club that no one wants to join, but for those who wo...
By Clinical Educator Teams • March 1, 2020 -
Unraveling Data Ownership
Amid ongoing concerns over data privacy and how patients’ data is used, who owns the data is both a crucial and complex question. Just who owns a patient’s data? It’s a question that is fraught with complications due to the sensitive nature of the information. Data has been described as the most ...
By Kim Ribbink • Jan. 1, 2020 -
Wearing Your health: The Case for Smart Clothing
As the wearable market continues to expand, the potential for smart clothing to monitor and manage health is breaking new ground. The market for wearables is continuing to grow as more companies enter the space and as more and more consumers acquire devices. According to IDTechEx, the market for ...
By Kim Ribbink • Nov. 19, 2019 -
Patient Care: Treatment to Cure
Moving the industry from a focus on treatment to a focus on prevention will require data, new financial incentives, and a change in how healthcare is delivered and paid for. Today, the U.S. healthcare system is a collection of disconnected components: health plans, hospital systems, pharmaceutica...
By PharmaVoice Team • Nov. 19, 2019 -
Can Healthcare Be Equitable?
Addressing disparities in health is key to achieving progress toward health equity, but in a complex environment how can these goals be achieved? According to the World Health Organization, equity is “the absence of avoidable or remediable differences among groups of people." From a healthcare pe...
By Kim Ribbink • Nov. 19, 2019 -
Technology Plus Science: New Company Model?
We asked a variety of experts what would happen if Apple, Amazon, Google or another big technology company bought a pharma company? Our experts are divided on the likelihood of this happening, but if it did, they say it would be transformational. For more than a decade we have been discussing the...
By Robin Robinson • Nov. 19, 2019